Recalls of prescription drugs, over-the-counter medications, and compounded pharmaceuticals.
Showing 21–40 of 438 recalls
Zeco LLC
CGMP Deviations: sterile water not used for production
Amneal Pharmaceuticals, LLC
Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.
Zydus Pharmaceuticals (USA) Inc
Cross contamination with other products
Medisca Inc.
CGMP Deviations and Presence of Particulate Matter: Glass
Winder Laboratories, LLC
Product Mix Up. A bottle of Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.
Hikma Injectables USA Inc
Labeling: Wrong Barcode
Viatris Inc
Failed Impurities/Degradation Specifications
Labeling: Label mix-up - ephedrine syringes mislabeled as phenylephrine.
Failed Tablet/Capsule Specifications: There is a potential for the imprint, M 122, to be missing on some tablets.
Coast Quality Pharmacy, LLC dba Anazao Health
Presence of Foreign Substance; Broken metal piece found embedded in tablet.
Dercher Enterprises, Inc., DBA Gordon Laboratories
cGMP Deviations
Esperion
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
Amneal Pharmaceuticals of New York, LLC
Failed Dissolution Specifications
Eli Lilly & Company
CGMP Deviations
Specialty Process Labs LLC
Failed Stability Specifications
Bausch Health Companies, Inc.
Subpotent Drug: Out of specification for assay